- The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair. Cancer letters. 2016 Academic Article GET IT
Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells.
Breast cancer research : BCR.
Times cited: 3
Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients.
Breast cancer research and treatment.
Times cited: 2